CVS Health (CVS) Expands its Federal Business to Include PBM - Credit Suisse

April 1, 2021 8:22 AM EDT Send to a Friend
Credit Suisse analyst A.J. Rice reiterated an Outperform rating and $91.00 price target on CVS Health (NYSE: CVS) after the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login